These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7187098)
1. The exclusion of patients from a clinical trial. Donner A Stat Med; 1982; 1(3):261-5. PubMed ID: 7187098 [TBL] [Abstract][Full Text] [Related]
2. Designing for nonparametric Bayesian survival analysis using historical controls. Van Ryzin J Cancer Treat Rep; 1980; 64(2-3):503-6. PubMed ID: 7407791 [TBL] [Abstract][Full Text] [Related]
3. A Bayesian approach to the interpretation of subgroup results in clinical trials. Donner A J Chronic Dis; 1982; 35(6):429-35. PubMed ID: 7076786 [TBL] [Abstract][Full Text] [Related]
4. Bayesian and non-Bayesian methods of inference. Small RD; Schor SS Ann Intern Med; 1983 Dec; 99(6):857-9. PubMed ID: 6360005 [No Abstract] [Full Text] [Related]
5. Predictive checking for Bayesian interim analyses in clinical trials. Daimon T Contemp Clin Trials; 2008 Sep; 29(5):740-50. PubMed ID: 18571477 [TBL] [Abstract][Full Text] [Related]
6. [Count on your beliefs. Bayes--not the P value--measures credence]. Taube A; Malmquist J Lakartidningen; 2001 Jul; 98(28-29):3208-11. PubMed ID: 11496808 [TBL] [Abstract][Full Text] [Related]
7. An extension of Bayesian expected power and its application in decision making. Liu F J Biopharm Stat; 2010 Sep; 20(5):941-53. PubMed ID: 20721783 [TBL] [Abstract][Full Text] [Related]
8. Bayesian statistics in oncology: a guide for the clinical investigator. Adamina M; Tomlinson G; Guller U Cancer; 2009 Dec; 115(23):5371-81. PubMed ID: 19691089 [TBL] [Abstract][Full Text] [Related]
9. A hybrid Bayesian adaptive design for dose response trials. Chang M; Chow SC J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172 [TBL] [Abstract][Full Text] [Related]
11. Simulation study for evaluating the performance of response-adaptive randomization. Du Y; Wang X; Jack Lee J Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340 [TBL] [Abstract][Full Text] [Related]
12. Jerome Cornfield and the methodology of clinical trials. Meier P Control Clin Trials; 1981 May; 1(4):339-45. PubMed ID: 7021066 [No Abstract] [Full Text] [Related]
13. Using Bayesian modeling in frequentist adaptive enrichment designs. Simon N; Simon R Biostatistics; 2018 Jan; 19(1):27-41. PubMed ID: 28520893 [TBL] [Abstract][Full Text] [Related]
14. A Bayesian approach to bioequivalence for the 2 x 2 changeover design. Selwyn MR; Dempster AP; Hall NR Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605 [TBL] [Abstract][Full Text] [Related]
15. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test. Doi M; Takahashi F; Kawasaki Y Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376 [TBL] [Abstract][Full Text] [Related]
16. A case for Bayesianism in clinical trials. Berry DA Stat Med; 1993 Aug; 12(15-16):1377-93; discussion 1395-404. PubMed ID: 8248653 [TBL] [Abstract][Full Text] [Related]
17. Effect of delayed observations on Bayesian decisions for binary data. Williamson PP; Choi SC J Biopharm Stat; 1998 Nov; 8(4):599-617. PubMed ID: 9855037 [TBL] [Abstract][Full Text] [Related]
18. An introduction to the Bayesian analysis of clinical trials. Lewis RJ; Wears RL Ann Emerg Med; 1993 Aug; 22(8):1328-36. PubMed ID: 8333640 [TBL] [Abstract][Full Text] [Related]